ESR1 and neoplasm: Replacing any of the six heterogenous datasets above (containing 67–85% ER+ tumours) with homogeneous datasets (containing only ER+ or ER- tumours) showed a dramatic reduction in the correlation between dataset or tumour number and prediction of recurrence (Additional File 8B).